White House Working on Possible Mass Mailing of Masks
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. President Joe Biden says the federal […]
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To date, […] When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other […] PORTAGE, Mich. (Reuters) – U.S. President Joe Biden on Friday secured a commitment from Pfizer Inc to double the COVID-19 […] As the U.S. rushes to administer COVID-19 vaccines, one California hospital has seen its infection rates among staff drop to […] SARS-CoV-2 genome is three times larger than influenza genome. Both consist of NRA molecules that mutate when replicate. It is […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Like many around the country, fourth-year […] FILE PHOTO: People wearing face masks use their cellphones at a subway station following the coronavirus disease (COVID-19) outbreak, in […] At least 109 employees at Winter Park Resort in Colorado have tested positive for COVID-19, the ski resort reported on […] (In Jan. 4 story, corrects paragraph 2 to say INO-4800 is being tested in three mid-stage trials, including one in […]Coronavirus
Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo
UK winning fight against covid variants as 1 in 3 adults in Britain have been vaccinated
Biden tours Pfizer vaccine plant as drugmaker promises to double supply
Calif. Hospital’s COVID-19 Infection Rate Drops to Single Digits Among Staff as 90 Percent Receive Vaccine
New tool enables study of SARS-CoV-2 mutant spectrum by ultrasequencing
Early Med School Graduations: Why This Year Is Different
China reports 8 new COVID-19 cases vs 12 a day earlier
109 Employees at Colorado Ski Resort Test Positive for COVID-19
Inovio expects to begin late-stage COVID-19 vaccine study in second quarter (Jan. 4)